XML 45 R32.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders’ Equity (Deficit) and Employee Incentive Plans (Tables)
 12 Months Ended
Jan. 31, 2023
Equity And Compensation Related Costs Share Based Payments [Abstract]  
Summary of Reserved Common Stock for Future Issuance
As of January 31, 2023, the Company has reserved common stock for future issuance as follows:
January 31, 2023January 31, 2022
Stock options outstanding7,819,480 9,167,495 
Shares available for future issuance under the 2021 Plan2,063,716 2,798,981 
Restricted stock units issued and outstanding4,502,982 1,497,558 
Shares available for future issuance under the 2023 Inducement Plan1,300,000 — 
ESPP954,159 830,000 
Common stock warrants105,350 105,350 
Total16,745,687 14,399,384 
Summary of Stock Option Activity under Stock Plans
The following table summarizes stock option activity under the Stock Plans for the year ended January 31, 2023 (aggregate intrinsic value in thousands):
Options Outstanding
Number of
Options		Weighted-
Average
Exercise
Price		Weighted-
Average
Contractual
Term		Aggregate
Intrinsic
Value
Balances as of January 31, 20229,150,821 $9.76 6.53$126,368 
Options exercised(801,079)$6.40 
Options granted— $— 
Options cancelled(530,262)$14.54 
Balances as of January 31, 20237,819,480 $9.78 5.21$51,606 
Options vested and expected to vest as of January 31, 20237,819,480 $9.78 5.21$51,606 
Options vested and exercisable as of January 31, 20236,525,570 $8.27 4.69$48,560 
Share-based Payment Arrangement, Restricted Stock Unit, Activity
The following table is a summary of RSU activity for the year ended January 31, 2023:
RSUs Outstanding
Number of RSUsWeighted Average Grant Date Fair Value Per Share
Balances as of January 31, 2022283,558 $43.76 
RSUs granted4,340,172 17.80
RSUs vested(452,477)23.07
RSUs forfeited(728,271)21.84
Balances as of January 31, 20233,442,982 $18.39 
The following is a summary of market-based RSU activity for the year ended January 31, 2023:
RSUs Outstanding
Number of RSUsWeighted Average Grant Date Fair Value Per Share
Balances as of January 31, 20221,214,000 $6.48 
RSUs granted14,000 $5.30 
RSUs vested— $— 
RSUs forfeited(168,000)$6.48 
Balances as of January 31, 20231,060,000 $6.47 
Schedule of Share-based Payment Award, Restricted Stock Units, Valuation Assumptions The grant fair value of each tranche was calculated using a Monte Carlo simulation model with the following assumptions:
Year Ended January 31,
20232022
Market-based awards:
Expected term (in years)4.75.0
Expected volatility63.0 %50.0 %
Risk-free interest rate2.9 %1.7 %
Dividend yield— — 
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions
The fair value of employee stock options was estimated using the following weighted-average assumptions:
Year Ended January 31,
202320222021
Stock Option Plans:
Expected term (in years)*6.16.1
Expected volatility*42.0 %40.0 %
Risk-free interest rate*1.0 %0.4 %
Dividend yield*— — 
*No stock options were granted during the year ended January 31, 2023.
Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions
The fair value of employee stock purchase rights for the offering period under the ESPP was determined on the date of grant using the Black-Scholes option-pricing model with the following weighted-average assumptions:
Year Ended January 31,
20232022
Employee Stock Purchase Plan:
Expected term (in years)0.91.0
Expected volatility63.0 %50.0 %
Risk-free interest rate0.6 %0.1 %
Dividend yield— — 
Schedule of Stock-Based Compensation Expense
Stock-based compensation expense, net of amounts capitalized was as follows (in thousands):
Year Ended January 31,
202320222021
Cost of revenue—subscription$535 $196 $69 
Cost of revenue—services433 196 54 
Research and development7,937 3,343 1,316 
Sales and marketing9,426 3,968 1,536 
General and administrative7,390 3,047 1,696 
Restructuring65 — — 
Total stock-based compensation expense$25,786 $10,750 $4,671